Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells

Biochem Pharmacol. 2011 Nov 1;82(9):1110-25. doi: 10.1016/j.bcp.2011.07.085. Epub 2011 Jul 23.

Abstract

Exposure of human Jurkat T cells to MG132 caused apoptosis along with upregulation of Grp78/BiP and CHOP/GADD153, activation of JNK and p38MAPK, activation of Bak, mitochondrial membrane potential (Δψm) loss, cytochrome c release, activation of caspase-12, -9, -3, -7, and -8, cleavage of Bid and PARP, and DNA fragmentation. However, these MG132-induced apoptotic events, with the exceptions of upregulation of Grp78/BiP and CHOP/GADD153 and activation of JNK and p38MAPK, were abrogated by overexpression of Bcl-xL. Pretreatment with the pan-caspase inhibitor z-VAD-fmk prevented MG132-induced apoptotic caspase cascade, but allowed upregulation of Grp78/BiP and CHOP/GADD153 levels, activation of JNK and p38MAPK, Δψm loss, and cleavage of procaspase-9 (47kDa) to active form (35kDa). Further analysis using selective caspase inhibitors revealed that caspase-12 activation was required for activation of caspase-9 and -3 to the sufficient level for subsequent activation of caspase-7 and -8. MG132-induced cytotoxicity, apoptotic sub-G(1) peak, Bak activation, and Δψm loss were markedly reduced by p38MAPK inhibitor, but not by JNK inhibitor. MG132-induced apoptotic changes, including upregulation of Grp78/BiP and CHOP/GADD153 levels, activation of caspase-12, p38MAPK and Bak, and mitochondria-dependent activation of caspase cascade were more significant in p56(lck)-stable transfectant JCaM1.6/lck than in p56(lck)-deficient JCaM1.6/vector. The cytotoxicity of MG132 toward p56(lck)-positive Jurkat T cell clone was not affected by the Src-like kinase inhibitor PP2. These results demonstrated that MG132-induced apoptosis was caused by ER stress and subsequent activation of mitochondria-dependent caspase cascade, and that the presence of p56(lck) enhances MG132-induced apoptosis by augmenting ER stress-mediated apoptotic events in Jurkat T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Caspase Inhibitors
  • Caspases / genetics
  • Caspases / metabolism
  • Endoplasmic Reticulum / drug effects*
  • Endoplasmic Reticulum / physiology
  • Endoplasmic Reticulum Chaperone BiP
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Jurkat Cells
  • Leupeptins / pharmacology*
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / genetics
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / metabolism*
  • MAP Kinase Kinase 4 / antagonists & inhibitors
  • Mitochondria / metabolism
  • Stress, Physiological / drug effects*
  • bcl-X Protein / genetics
  • bcl-X Protein / metabolism
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors

Substances

  • BCL2L1 protein, human
  • Caspase Inhibitors
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human
  • Leupeptins
  • bcl-X Protein
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Caspases
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde